Publications by authors named "Hugues Bourgeois"

Claim this Profile
P
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC Trial.
Jose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi, William Jacot, Thomas Bachelot, Hugues Bourgeois

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The place of the relative at the time of the announcement of cancer progression: BABEL - a mixed-methods study.
Isabelle Ingrand, Estelle Laurent, Thierry Lecomte, Oana Cojocarasu, Joëlle Egreteau, Hugues Bourgeois

Palliat Support Care· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Hugues Bourgeois

Int J Gynecol Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Gilles Freyer, Noelia Martinez-Jañez, Bożena Kukielka-Budny, Malgorzata Ulanska, Hugues Bourgeois

Breast· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.
François-Clément Bidard, Nicolas Kiavue, William Jacot, Thomas Bachelot, Sylvain Dureau, Hugues Bourgeois

J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Option for Pain Prevention Using a Therapeutic Virtual Reality Solution for Bone Marrow Biopsy (REVEH Trial): Open-Label, Randomized, Multicenter, Phase 3 Study.
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Hugues Bourgeois

J Med Internet Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial.
Jonas Dubu, Sébastien Boyas, Virginie Roland, Sébastien Landry, Anne-Lise Septans, Hugues Bourgeois

JMIR Res Protoc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Florence Joly, Michel Fabbro, Dominique Berton, Justine Lequesne, Amélie Anota, Hugues Bourgeois

Gynecol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromuscular, Psychological, and Sleep Predictors of Cancer-Related Fatigue in Cancer Patients.
Martin Chartogne, Abderrahmane Rahmani, Sébastien Landry, Hugues Bourgeois, Nicolas Peyrot

Clin Breast Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
Laurent Zelek, Philippe Debourdeau, Hugues Bourgeois, Jean Philippe Wagner, Fabien Brocard

Oncologist· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.
Bora Lim, David A Potter, Mohamad A Salkeni, Paula Silverman, Tufia C Haddad, Hugues Bourgeois

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer.
Sandro Pignata, Giovanni Scambia, Alessandro Villanucci, Emanuele Naglieri, Mikel Arruti Ibarbia, Hugues Bourgeois

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
Luc Cabel, Frédérique Berger, Paul Cottu, Delphine Loirat, Aurore Rampanou, Hugues Bourgeois

Br J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.
Marie-Mélanie Gac, Cécile Loaec, Johanna Silve, Edouard Vaucel, Paule Augereau, Hugues Bourgeois

Eur J Surg Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
François-Clément Bidard, William Jacot, Nicolas Kiavue, Sylvain Dureau, Amir Kadi, Hugues Bourgeois

JAMA Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.
William Jacot, Paul Cottu, Frederique Berger, Coraline Dubot, Laurence Venat-Bouvet, Hugues Bourgeois

Breast Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of cancer patients with oral therapy at home in Brittany and Pays de la Loire areas: Survey (end of 2016) and cartography].
Françoise Grudé, Fanny Marhuenda, Delphine Déniel-Lagadec, Réjane Bessard, Marc Pracht, Hugues Bourgeois

Bull Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of a web-mediated management of febrile neutropenia related to chemotherapy (Bioconnect).
Fabrice Denis, Eric Voog, Yoann Pointreau, Hugues Bourgeois, Valérie Seegers

Support Care Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of PONDx, a prospective multicenter study of the Oncotype DX breast cancer assay: Real-life utilization and decision impact in French clinical practice.
Elsa Curtit, Jean-Michel Vannetzel, Jean-Claude Darmon, Sophie Roche, Hugues Bourgeois

Breast· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual quality of life evaluation after treatment among women with breast cancer under 35 years old.
Anaïse Blouet, Marie Zinger, Olivier Capitain, Sébastien Landry, Hugues Bourgeois

Support Care Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
Ulrich Keilholz, Janice M Mehnert, Sebastian Bauer, Hugues Bourgeois, Manish R Patel

J Immunother Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
Sébastien Landry, Guillaume Chasles, Yoann Pointreau, Hugues Bourgeois, Sébastien Boyas

Oncology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44-S45].
Wolfgang Janni, Arlene Chan, Arnd Nusch, Emilio Alba, Thomas Bachelot, Hugues Bourgeois

Breast· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Eric Voog, Loïc Campion, Pauline du Rusquec, Hugues Bourgeois, Julien Domont

Support Care Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Elsa Curtit, Xavier Pivot, Julie Henriques, Sophie Paget-Bailly, Pierre Fumoleau, Hugues Bourgeois

Breast Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis